Table 2.
Outcome variables (Mean±SD) |
Range | Control (N=42) |
Intervention (N=49) |
Total (N=91) |
p |
---|---|---|---|---|---|
Symptom Distress | |||||
Physical symptomsa | 0.8–2.4 | 1.40±0.38 | 1.42±0.50 | 1.41±0.45 | .82 |
Psycho logical symptomsb | 0.8–2.9 | 1.67±0.50 | 1.72±0.70 | 1.70±0.61 | .66 |
Psychosomatic symptomsc | 0.8–3.5 | 1.67±0.63 | 1.89±0.84 | 1.75±0.75 | .35 |
Total | 0.8–2.6 | 1.58±0.39 | 1.65±0.58 | 1.62±0.50 | .66 |
Symptom Frequency | |||||
Psychological symptomsd
(log transformed) |
0.9–3.6 | 1.93±0.67 | 1.84±0.73 | 1.89±0.70 | .57 |
Theory-based variables | |||||
Attitudes | 1.2–5.9 | 3.49 (2.03) | 4.06 (1.89) | 3.80 (1.96) | .17 |
Social influences | 1.1–6.8 | 5.72 (1.45) | 5.61 (1.28) | 5.67 (1.36) | .71 |
Perceived barriers | 1.0–3.9 | 3.12 (0.55) | 2.98 (0.61) | 3.05 (0.59) | .27 |
Self-efficacy | 1.1–8.8 | 5.96 (1.56) | 6.16 (1.77) | 6.06 (1.67) | .55 |
SD = standard deviation/ All categories of symptoms were measured using the MSAS-SF.
Physical symptoms included ‘nausea,’ ‘vomiting,’ ‘shortness of breath,’ ‘sweats,’ ‘feeling bloated,’ ‘problems with urination,’ ‘diarrhea,’ ‘weight loss,’ ‘itching,’ ‘changes in skin,’ ‘constipation,’ ‘swelling of arms or legs,’ ‘numbness/tingling in hands/feet,’ ‘lack of appetite,’ and ‘pain.’
Psychological symptoms included ‘difficulty concentrating’ and ‘problems with sexual interest or activity.’
Psychosomatic symptoms included ‘difficulty sleeping’ and ‘dizziness.’
Psychological symptoms included ‘feeling sad,’ ‘worrying,’ ‘feeling irritable,’ and ‘feeling nervous.’